Trovagene said this week that Carlo Croce has joined its scientific advisory board.
Croce is chair of human genetics and chairman of molecular virology, immunology, and medical genetics at the Genetics Institute at Ohio State University. He also serves as director of the human cancer genetics program at the institute.
Croce also co-founded Centocor, which was acquired by Johnson & Johnson in 1999.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
